These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 12931627)

  • 1. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
    Oka Y; Tsuboi A; Sugiyama H
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
    Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
    Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 peptide vaccine for the treatment of cancer.
    Oka Y; Tsuboi A; Oji Y; Kawase I; Sugiyama H
    Curr Opin Immunol; 2008 Apr; 20(2):211-20. PubMed ID: 18502632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer vaccines and immunotherapies: emerging perspectives.
    Henderson RA; Mossman S; Nairn N; Cheever MA
    Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy targeting Wilms' tumor gene WT1 product.
    Sugiyama H
    Expert Rev Vaccines; 2005 Aug; 4(4):503-12. PubMed ID: 16117707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [WT1 peptide-based immunotherapy].
    Sugiyama H
    Nihon Rinsho; 2005 Jun; 63(6):1101-9. PubMed ID: 15948398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological therapy of human tumors by gene-modified cellular vaccines.
    Parmiani G
    Folia Biol (Praha); 2000; 46(6):207-9. PubMed ID: 11140852
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer vaccines.
    Chekhun VF
    Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical aspects of cancer immunity.
    Moore GE
    Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunotherapy of cancer].
    Gil Extremera B
    Rev Clin Esp; 1976 Aug; 142(3):281-91. PubMed ID: 788067
    [No Abstract]   [Full Text] [Related]  

  • 12. WT1 peptide vaccine, one of the most promising cancer vaccines: its present status and the future prospects.
    Oka Y; Sugiyama H
    Immunotherapy; 2010 Sep; 2(5):591-4. PubMed ID: 20874639
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer immunotherapy targeting WT1 protein.
    Sugiyama H
    Int J Hematol; 2002 Aug; 76(2):127-32. PubMed ID: 12215010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunology of cancer: avenues to immunotherapy.
    Woods AH
    Ariz Med; 1973 Jul; 30(7):463-83. PubMed ID: 4581414
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy of malignant tumors].
    Adolphs HD
    Med Klin; 1975 Feb; 70(7):255-66. PubMed ID: 1091835
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting cancer therapy.
    Begent RH
    Br J Cancer; 1999 Jul; 80 Suppl 1():104-9. PubMed ID: 10466768
    [No Abstract]   [Full Text] [Related]  

  • 18. The contenders. Vaccines and viruses take aim at cancer cells.
    Clancy F
    Minn Med; 2005 Apr; 88(4):24-8. PubMed ID: 15940888
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer vaccines: toward the next revolution in cancer therapy.
    Emens LA
    Int Rev Immunol; 2006; 25(5-6):259-68. PubMed ID: 17169776
    [No Abstract]   [Full Text] [Related]  

  • 20. Wilms' tumor 1 (WT1) peptide immunotherapy for gynecological malignancy.
    Ohno S; Kyo S; Myojo S; Dohi S; Ishizaki J; Miyamoto K; Morita S; Sakamoto J; Enomoto T; Kimura T; Oka Y; Tsuboi A; Sugiyama H; Inoue M
    Anticancer Res; 2009 Nov; 29(11):4779-84. PubMed ID: 20032435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.